???global.info.a_carregar???
Ana Barbas. Publicou 23 artigos em revistas especializadas. Possui 1 livro(s). Atua na(s) área(s) de Ciências Médicas e da Saúde com ênfase em Biotecnologia Médica com ênfase em Biotecnologia Aplicada à Saúde.
Identification

Personal identification

Full name
Ana Barbas

Citation names

  • Barbas, Ana

Author identifiers

Ciência ID
711F-FAE7-E21E
ORCID iD
0000-0002-6245-8549

Telephones

Telephone
  • 214469441 (Professional)

Addresses

  • iBET, Avenida da Republica, EAN, 2781-901, Oeiras, Oeiras, Portugal (Professional)

Websites

Knowledge fields

  • Medical and Health Sciences - Medical Biotechnology - Health-Related Biotechnology

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese (Mother tongue)
English Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2)
German Intermediate (B1) Intermediate (B1) Intermediate (B1) Intermediate (B1) Intermediate (B1)
French Elementary (A2) Elementary (A2) Elementary (A2) Elementary (A2) Elementary (A2)
Education
Degree Classification
2008/01/01 - 2009/10/01
Concluded
Ciências da Engenharia e Tecnologia (Pós-doutoramento)
Major in Biotecnologia
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
n/a
2003/09/01 - 2007/12/14
Concluded
Ciências e Engenharias Químicas e Biológicas (Doutoramento)
Major in Ciência Biológicas
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
"Functional and Structural Studies on Escherichia coli RNase II: a crucial enzyme in RNA metabolism. " (THESIS/DISSERTATION)
unanimidade
1994/09/15 - 1999/07/15
Concluded
Química Aplicada (Licenciatura)
Major in Biotecnologia
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
"Production of Recombinant Cytokines in Escherichia coli - Case study of interferon alha" (THESIS/DISSERTATION)
15
Affiliation

Science

Category
Host institution
Employer
2015/01/01 - Current Contracted Researcher (Research) Bayer Portugal SA, Portugal
Bayer Portugal SA, Portugal
(...)
2009/11/01 - 2014/12/31 Researcher (Research) Instituto de Biologia Experimental e Tecnológica, Portugal
Instituto de Biologia Experimental e Tecnológica, Portugal
1999/09/15 - 2003/07/15 Researcher (Research) Biotecnol SA, Portugal
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
Projects

Grant

Designation Funders
2013/07 - 2015/12 Combining siRNA and AAV therapy approaches to target human basal-like breast cancer: from vector development to anti-tumor efficacy evaluation. Universidade de Coimbra
2012/03 - 2015/09 Viral Capture and Purification System: Smart macroporous structures for the affinity purification of retroviral particles Universidade de Coimbra
2012/03 - 2015/09 Development of function blocking antibodies using Phage Display Technology: Inhibiton of the Notch1 signaling pathway by function blocking anti-jagged 1 antibody. Universidade de Coimbra
2013/07 - 2014/09 Development of a scalable strategy for stem cells purification Universidade de Coimbra
2008/01 - 2011/03 Elucidating the Critical Role of RNase II family of Enzymes in RNA metabolism: Structural and Functional Studies Universidade de Coimbra
2008/01 - 2011/03 Biochemical and Structural Studies of UDP-Glucose Dehydrogenases Universidade de Coimbra
2007/11 - 2011/03 RNase II-like enzymes and non-coding RNAs and their role in the pathogenicity of Streptococcus pneumoniae Universidade de Coimbra
2007/01 - 2009/06 The role of small non-coding RNAs and RNases on the pathogenicity of Salmonella. Universidade de Coimbra
2007/01 - 2009/03 The role of RNase R and its Homologues in the Control of Gene Expression:Structural and Functional Studies Universidade de Coimbra
2005/09 - 2008/02 The role of small non-coding RNAs and RNases on the pathogenicity of Salmonella. Fundação para a Ciência e a Tecnologia
Outputs

Publications

Book
  1. Arraiano, C.M.; Barbas, A.; Amblar, M.. Chapter 8 Characterizing Ribonucleases In Vitro. Examples of Synergies between Biochemical and Structural Analysis. 2008.
    10.1016/S0076-6879(08)02208-8
Journal article
  1. Catarina Pinto; Gabriela Silva; Ana S. Ribeiro; Mónica Oliveira; Manuel Garrido; Vanessa S. Bandeira; André Nascimento; et al. "Evaluation of AAV-mediated delivery of shRNA to target basal-like breast cancer genetic vulnerabilities". Journal of Biotechnology 300 (2019): 70-77. https://doi.org/10.1016/j.jbiotec.2019.05.016.
    10.1016/j.jbiotec.2019.05.016
  2. Sales-Dias J; Silva G; Lamy M; Ferreira A; Barbas A. "The Notch ligand DLL1 exerts carcinogenic features in human breast cancer cells.". PloS one (2019): http://europepmc.org/abstract/med/31107884.
    10.1371/journal.pone.0217002
  3. Ferreira A; Lamy M; Margarida Rocha M; Silva G; Bandeiras TM; Barbas A. "Production and characterization of a novel Delta-like 1 functional unit as a tool for Notch pathway activation and generation of a specific antibody.". Protein expression and purification (2018): http://europepmc.org/abstract/med/29366964.
    10.1016/j.pep.2018.01.008
  4. Loureiro, L.R.; Sousa, D.P.; Ferreira, D.; Chai, W.; Lima, L.; Pereira, C.; Lopes, C.B.; et al. "Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids". Scientific Reports 8 1 (2018): http://www.scopus.com/inward/record.url?eid=2-s2.0-85051658578&partnerID=MN8TOARS.
    10.1038/s41598-018-30421-w
  5. Goncalves, J.; Santos, M.; Acurcio, R.; Iria, I.; Gouveia, L.; Matos Brito, P.; Catarina Cunha-Santos, A.; et al. "Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition". Alimentary Pharmacology and Therapeutics 48 5 (2018): 507-522. http://www.scopus.com/inward/record.url?eid=2-s2.0-85051269231&partnerID=MN8TOARS.
    10.1111/apt.14808
  6. Lamy, M.; Ferreira, A.; Dias, J.S.; Braga, S.; Silva, G.; Barbas, A.. "Notch-out for breast cancer therapies". New Biotechnology 39 (2017): 215-221. http://www.scopus.com/inward/record.url?eid=2-s2.0-85028763617&partnerID=MN8TOARS.
    10.1016/j.nbt.2017.08.004
  7. Fernandes, C.S.M.; Barbosa, I.; Castro, R.; Pina, A.S.; Coroadinha, A.S.; Barbas, A.; Roque, A.C.A.. "Retroviral particles are effectively purified on an affinity matrix containing peptides selected by phage-display". Biotechnology Journal 11 12 (2016): 1513-1524. http://www.scopus.com/inward/record.url?eid=2-s2.0-84995387896&partnerID=MN8TOARS.
    10.1002/biot.201600025
  8. Loureiro, L.R.; Carrascal, M.A.; Barbas, A.; Ramalho, J.S.; Novo, C.; Delannoy, P.; Videira, P.A.. "Challenges in antibody development against Tn and sialyl-Tn antigens". Biomolecules 5 3 (2015): 1783-1809. http://www.scopus.com/inward/record.url?eid=2-s2.0-85012077616&partnerID=MN8TOARS.
    10.3390/biom5031783
  9. Reis, F.P.; Barbas, A.; Klauer-King, A.A.; Tsanova, B.; Schaeffer, D.; López-Viñas, E.; Gómez-Puertas, P.; Van Hoof, A.; Arraiano, C.M.. "Erratum: Correction: Modulating the RNA Processing and Decay by the Exosome: Altering Rrp44/Dis3 Activity and End-Product (PLoS ONE (2015) 10:8 (e0136810) (doi:10.1371/journal.pone.0136810))". PLoS ONE 10 8 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84942852941&partnerID=MN8TOARS.
    10.1371/journal.pone.0136810
  10. Reis, F.P.; Barbas, A.; Klauer-King, A.A.; Tsanova, B.; Schaeffer, D.; López-Viñas, E.; Gómez-Puertas, P.; Van Hoof, A.; Arraiano, C.M.. "Modulating the RNA processing and decay by the exosome: Altering Rrp44/Dis3 activity and end-product". PLoS ONE 8 11 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84893157627&partnerID=MN8TOARS.
    10.1371/journal.pone.0076504
  11. Barbas, A.; Popescu, A.; Frazão, C.; Arraiano, C.M.; Fialho, A.M.. "Rossmann-fold motifs can confer multiple functions to metabolic enzymes: RNA binding and ribonuclease activity of a UDP-glucose dehydrogenase". Biochemical and Biophysical Research Communications 430 1 (2013): 218-224. http://www.scopus.com/inward/record.url?eid=2-s2.0-84872422260&partnerID=MN8TOARS.
    10.1016/j.bbrc.2012.10.091
  12. Matos, R.G.; Barbas, A.; Gómez-Puertas, P.; Arraiano, C.M.. "Swapping the domains of exoribonucleases RNase II and RNase R: Conferring upon RNase II the ability to degrade ds RNA". Proteins: Structure, Function and Bioinformatics 79 6 (2011): 1853-1867. http://www.scopus.com/inward/record.url?eid=2-s2.0-79955713801&partnerID=MN8TOARS.
    10.1002/prot.23010
  13. Arraiano, C.M.; Matos, R.G.; Barbas, A.. "RNase II: The finer details of the modus operandi of a molecular killer". RNA Biology 7 3 (2010): http://www.scopus.com/inward/record.url?eid=2-s2.0-85011942110&partnerID=MN8TOARS.
  14. Matos, R.G.; Barbas, A.; Arraiano, C.M.. "Comparison of EMSA and SPR for the characterization of RNA-RNase II complexes". Protein Journal 29 6 (2010): 394-397. http://www.scopus.com/inward/record.url?eid=2-s2.0-77956265586&partnerID=MN8TOARS.
    10.1007/s10930-010-9265-1
  15. Domingues, S.; Matos, R.G.; Reis, F.P.; Fialho, A.M.; Barbas, A.; Arraiano, C.M.. "Biochemical characterization of the RNase II family of exoribonucleases from the human pathogens Salmonella typhimurium and Streptococcus pneumoniae". Biochemistry 48 50 (2009): 11848-11857. http://www.scopus.com/inward/record.url?eid=2-s2.0-72449207486&partnerID=MN8TOARS.
    10.1021/bi901105n
  16. Matos, R.G.; Barbas, A.; Arraiano, C.M.. "RNase R mutants elucidate the catalysis of structured RNA: RNA-binding domains select the RNAs targeted for degradation". Biochemical Journal 423 2 (2009): 291-301. http://www.scopus.com/inward/record.url?eid=2-s2.0-70350111321&partnerID=MN8TOARS.
    10.1042/BJ20090839
  17. Barbas, A.; Matos, R.G.; Amblar, M.; López-Viñas, E.; Gomez-Puertas, P.; Arraiano, C.M.. "Determination of key residues for catalysis and RNA cleavage specificity. One mutation turns RNase II Into a "super-enzyme"". Journal of Biological Chemistry 284 31 (2009): 20486-20498. http://www.scopus.com/inward/record.url?eid=2-s2.0-68949127239&partnerID=MN8TOARS.
    10.1074/jbc.M109.020693
  18. Schaeffer, D.; Tsanova, B.; Barbas, A.; Reis, F.P.; Dastidar, E.G.; Sanchez-Rotunno, M.; Arraiano, C.M.; Van Hoof, A.. "The exosome contains domains with specific endoribonuclease, exoribonuclease and cytoplasmic mRNA decay activities". Nature Structural and Molecular Biology 16 1 (2009): 56-62. http://www.scopus.com/inward/record.url?eid=2-s2.0-58149236691&partnerID=MN8TOARS.
    10.1038/nsmb.1528
  19. Barbas, A.; Matos, R.G.; Amblar, M.; López-Viñas, E.; Gomez-Puertas, P.; Arraiano, C.M.. "New insights into the mechanism of RNA degradation by ribonuclease II: Identification of the residue responsible for setting the RNase II end product". Journal of Biological Chemistry 283 19 (2008): 13070-13076. http://www.scopus.com/inward/record.url?eid=2-s2.0-45149086359&partnerID=MN8TOARS.
    10.1074/jbc.M709989200
  20. Amblar, M.; Barbas, A.; Gomez-Puertas, P.; Arraiano, C.M.. "The role of the S1 domain in exoribonucleolytic activity: Substrate specificity and multimerization". RNA 13 3 (2007): 317-327. http://www.scopus.com/inward/record.url?eid=2-s2.0-33847247982&partnerID=MN8TOARS.
    10.1261/rna.220407
  21. Frazão, C.; McVey, C.E.; Amblar, M.; Barbas, A.; Vonrhein, C.; Arraiano, C.M.; Carrondo, M.A.. "Unravelling the dynamics of RNA degradation by ribonuclease II and its RNA-bound complex". Nature 443 7107 (2006): 110-114. http://www.scopus.com/inward/record.url?eid=2-s2.0-33748414894&partnerID=MN8TOARS.
    10.1038/nature05080
  22. Amblar, M.; Barbas, A.; Fialho, A.M.; Arraiano, C.M.. "Characterization of the Functional Domains of Escherichia coli RNase II". Journal of Molecular Biology 360 5 (2006): 921-933. http://www.scopus.com/inward/record.url?eid=2-s2.0-33745951483&partnerID=MN8TOARS.
    10.1016/j.jmb.2006.05.043
  23. McVey, C.E.; Amblar, M.; Barbas, A.; Cairrão, F.; Coelho, R.; Romáo, C.; Arraiano, C.M.; Carrondo, M.A.; Frazão, C.. "Expression, purification, crystallization and preliminary diffraction data characterization of Escherichia coli ribonuclease II (RNase II)". Acta Crystallographica Section F: Structural Biology and Crystallization Communications 62 7 (2006): 684-687. http://www.scopus.com/inward/record.url?eid=2-s2.0-33745684855&partnerID=MN8TOARS.
    10.1107/S1744309106021506
Activities

Journal scientific committee

Journal title (ISSN) Publisher
2005 - Current Journal of Biochemistry and Biotechnology
Distinctions

Award

2011 Terry Fox Grants 2012 Award for Cancer Research
Liga Portuguesa Contra o Cancro, Portugal
2011 L’Oreal Portugal Award for Women in Science
Fundação para a Ciência e a Tecnologia, Portugal

L'Oreal Canada, Canada

Fondation L'Oréal, France